Key documents:

• Programme

Presentations:

Plenary session: Trends and developments in high-risk opioid use: a multi-indicator perspective

• Prevalence and trends in opioid use in Europe: a multi-indicator perspective - Danica Thanki and Linda Montanari
• Long-term trends in opioid use in the USA: possible resurgence of heroin - Michael A. Cala
• Recent strong decrease of opioid use in Austria: a cross-indicator analysis - Alexander Grabenhofer-Eggerth
• Estimating the number of and trends in opiate, cocaine, and amphetamine users in Berlin - Ludwig Kraus
• I have a dream: the Drug situation Index (DSI) - Guus Cruts

Plenary session: Opioid treatment coverage and treatment need

• Current trends in opiod substitution treatment: saturation or unmet need? - Alessandro Pirona
• Participation in OST treatment and HRDU estimates: a data analysis - Danica Thanki and Eleni Kalamara
• Substitution treatment coverage calculation in Norway - Ellen Amudsen
• In-depth analysis of substitution treatment data in combination with other data (e.g. police) and theoretical considerations to identify stable clients - Martin Busch
• Prevalence of HIV and risk behaviours among injecting drug users in Tallin, Estonia, including discussion on treatment access and perceived treatment need - Sigrid Vorobjov and Maris Salekesin

Parallel session 1: Ageing drug users: situation, co-morbidities and responses

• Mortality and treatment interventions among 200 000 opioid users in England, 2005-09 - Tim Millar
• Do we need special programs for ageing drug users? - Andrej Kastelic
• Main medical problems of ageing PDU's in OST - Lubomir Okruhlica
• Multimorbidity in ageing drug users: a Scottish perspective - Saket Priyadarshi

Parallel session 2: Vulnerable populations and drugs problems

• Public health needs of prisoners in English prisoners - Kieran Lynch
• An innovative model of assessment and intervention for drug-addicted mothers and their children: clinical and research issues - Nicolleta Capra
• The prevalence and course of substance use among Dutch homeless people and teh relationship with housing after 1.5 years - Dike van de Mheen
• Travellers and problem drug use in Ireland - Suzi Lyons
• Drug consumption among roma population - Bogdan Gheorghe

Parallel session 3: Monitoring systems and Information technologies in drug use and drug treatment adata collection

• The Italian Interactive system for addiction data management - Bruno Genetti
• Data management of the largest EMCDDA data set: TDI - Bruno Guarita
• LADIS, the Dutch Information System on Alcohol and Drugs - Wil Kuijpers
• NDTMS - a perspective on the English system - Andrew Jones

Plenary session: The added value of treatment systems approach in services planning

• How system-based treatment monitoring can inform policy-making - Kerstin Stenius
• A systems apporach to substance use in Canada - Rebecca Jesseman

Parallel session 4: Stimulant drugs

• The effects of the State Sanitary Inspectorare activity in the field of new psychoactive substances (NPS) - Tomasz Bialas
• Update on syntethic cathinones injection in Hungary - Róbert Csák
• Update on syntethic cathinones injection in Romani - Bogdan Gheorghe
• Risk of HCV Infection among heroinand metamphetamine users - Zuzana Alexandercikova

Parallel session 5: High-risk benzodiasepine use

• (Mis)use of benzodiazepines among high-risk drug users - Felice Nava
• Clients demanding treatment for use of benzodiazepinesin Europe - Linda Montanari
• Clinical perspective on implications of use of benzodiazepinesamong clients of drug treatment services - challenges and best practice - Lubomir Okruhlica

Parallel session 6: Adaptation of drug treatment in the situation of changing needs

• Therapeutic communities: adaptations and the role of monitoring - Domingos Duran
• A clinical view from inpatient treatment: adaptations and the role of monitoring - Wibke Voigt
• A quasi-federal view: adaptations and the role of monitoring - Rosario Sendino
• Monitoring facilities vs monitoring service provision: a national discussion - Barbara Braun

Plenary session: High-risk cannabis use

• Trends in high-risk cannabis use in treatment demand and multi-indicator analysis - Linda Montanari and Danica Thanki
• Cannabis treatment: the EMCDDA insights - Marica Ferri
• Trends in cannabis use and cannabis-related treatment demand in Switzerland - Etienne Maffli
• Cannabis use in France - Tanja Bastianic
• Psychiatric comorbidity and cannabis use - Maria Francina Fonseca Casals

Plenary session: Cost of treatment and the impact of economic recession on drug users and drug treatment

• The impact of economic recession on funding of drug services across EU and Norway - Cláudia Costa Storti
• National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe - Clive Richardson
• Designing and implementing responsive durg policies under fiscal constraints: the case of Greece - Meni Malliori
• Estimating OST costs in Italy - Bruno Genetti

Plenary session: Treatment outcomes

• What are the outcomes for assessing drug treament? A review of long-term observational studies on the treatment of opioid dependences - Lucas Wiessing
• Risk taking and outcomes in the English treatment system - Andrew Jones
• What can nine years of treatment data demonstrate about long term outcomes, cost effectiveness and the changing of drug use in England - Jonathan Knight

Plenary session: Evaluating best practice: can we monitor treatment effectiveness accross Europe?

• Making sense of available data: developing a framework to support knowledge exchange - Marica Ferri
• Drug treatment monitoring and evidence based practice. A mechanism for improving quality and outcomes? - Jonathan Knight and Luke Mitcheson
• Combination inteventions to prevent health related problems in people who inject drugs - can they be monitored using routine data? - Peter Vickerman
• How can modelling contribute to the evaluation of drug treatment in Europe? - Catherine Comiskey
• New indicators for monitoring drug users health: a comparison accross countries - Carla Rossi